由HSP70介导的线粒体动力学和自代表了胰腺癌的新型脆弱性
Giulia D S Ferretti1,2, Colleen E Quaas1,2, Irene Bertolini3
1Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.
热冲击蛋白70 (HSP70) 通过影响线粒体和自,驱动胰腺癌的生长. 抑制HSP70和自可以在治疗胰腺管道腺癌 (PDAC) 中发挥作用.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 胰腺管腺癌 (PDAC) 是一种致命的癌症,治疗选择有限.
- 热冲击蛋白70 (HSP70) 的过度表达与侵袭性癌症和不良结果有关.
- HSP70在PDAC进展中的作用及其潜在机制仍然不清楚.
研究的目的:
- 研究HSP70在PDAC发育和进展中的作用.
- 阐明HSP70促进PDAC瘤发生的分子机制.
- 评估HSP70抑制的治疗潜力,单独或与自抑制剂结合,用于PDAC治疗.
主要方法:
- 在PDAC组织中分析HSP70表达.
- 在PDAC模型中,HSP70的遗传和药理抑制.
- 评估线粒体动力学,细胞亡和自.
- 使用HSP70抑制剂和氧化 (HCQ) 的组合疗法研究.
主要成果:
- 在分析的癌症中,PDAC表现出最高的HSP70表达,与瘤等级和转移相关.
- 抑制HSP70会破坏线粒体功能,通过PINK1/DRP1途径诱导亡,并增强抗瘤活性.
- 抑制HSP70上调调节贝克林-1酸化,这表明与自有关.
- 联合抑制HSP70和自 (使用HCQ) 在体内协同减少瘤生长.
结论:
- HSP70是PDAC的一个关键驱动器,调节线粒体动力学和自.
- 针对HSP70,特别是与自抑制相结合,代表了PDAC的有前途的治疗策略.
更多相关视频
08:40Visualization of Endogenous Mitophagy Complexes In Situ in Human Pancreatic Beta Cells Utilizing Proximity Ligation Assay
Published on: May 2, 2019
07:04Author Spotlight: Assessment of Mitophagy Flux in Pancreatic β-Cells Using Effective and Robust Complementary Approaches
Published on: September 15, 2023
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
PI3K/mTOR/AKT Signaling Pathway
Mitochondrial Membranes
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
